PROTALIX BIOTHERAPEUTICS INC - COM (PLX)

CUSIP: 74365A101

Q3 2015 13F Holders as of 30 Sep 2015

Type / Class
Equity / COM
Total 13F shares
27,846,747
Share change
-1,243,294
Total reported value
$32,856,884
Put/Call ratio
137%
Price per share
$1.18
Number of holders
30
Value change
-$1,556,593
Number of buys
8
Number of sells
15

Quarterly Holders Quick Answers

What is CUSIP 74365A101?
CUSIP 74365A101 identifies PLX - PROTALIX BIOTHERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PROTALIX BIOTHERAPEUTICS INC - COM (PLX) as of Q3 2015

As of 30 Sep 2015, PROTALIX BIOTHERAPEUTICS INC - COM (PLX) was held by 30 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 27,846,747 shares. The largest 10 holders included Camber Capital Management LLC, FEDERATED INVESTORS INC /PA/, BAILLIE GIFFORD & CO, Visium Asset Management, LP, MENORA MIVTACHIM HOLDINGS LTD., DAFNA Capital Management LLC, CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM, Mivtachim The Workers Social Insurance Fund Ltd. (Under Special Management), BRIDGEWAY CAPITAL MANAGEMENT INC, and STATE OF WISCONSIN INVESTMENT BOARD. This page lists 30 institutional shareholders reporting positions in this security for the Q3 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.